UW Obstetric-Fetal Pharmacology Research Unit
华盛顿大学产胎儿药理学研究单位
基本信息
- 批准号:7895314
- 负责人:
- 金额:$ 86.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAnimal ModelAnimalsApplications GrantsAreaBasic ScienceBiochemicalCYP2C9 geneChildChronic DiseaseClinicalClinical DataClinical PharmacologyClinical TrialsCytochrome P450DataDevelopmentDiscipline of obstetricsDiseaseDoseDrug KineticsDrug usageElderlyEnvironmentEnzymesExposure toFetusFundingGestational DiabetesGlyburideGoalsHealth ProfessionalIn VitroInfantInsulinLabelMembrane Transport ProteinsMetforminNatural HistoryOrganOrganic Cation TransporterOrphanOutcomePerformancePharmaceutical PreparationsPharmacodynamicsPharmacogeneticsPharmacologyPharmacotherapyPhasePhenotypePhysiciansPhysiologicalPopulationPostpartum PeriodPre-Clinical ModelPregnancyPregnant WomenResearchResearch InfrastructureResourcesSafetyScientistSiteSpecialistStagingSystemTechnologyTestingTherapeuticThird Pregnancy TrimesterTimeToxic effectTrainingTranslational ResearchUniversitiesWashingtonWomanWorkbaseclinical materialdrug efficacyexperiencefetalin vivointerestmenmodels and simulationnamed groupnewsnonhuman primatepharmacokinetic modelplacental transferpregnantresearch studysafety study
项目摘要
DESCRIPTION (provided by applicant): The overall objective of this grant proposal is to establish an Obstetric-Fetal Pharmacology Unit at the University of Washington. The major goal of the pharmacology unit will be to characterize the pharmacokinetics and pharmacodynamics of drugs that are of therapeutic value during pregnancy and whose clinical pharmacology is altered by the pregnant state. The general research focus will be cytochrome P450 enzymes and membrane transporters. This proposal describes the available environment and resources at the University of Washington for establishing a successful and productive Obstetric-Fetal Pharmacology Research Unit. As a demonstration of our research interests and capabilities the following translational research studies that integrate our strengths in clinical and basic sciences are proposed to evaluate the following study aims.
1. We aim to determine whether the in vivo activities of CYP2C9 and organic cation transporter (OCT) are altered through stages of pregnancy using the following phenotype markers: glyburide for CYP2C9 and metformin for OCT. Phase I (population pharmacokinetic analysis) and Phase II (pharmacokinetic / pharmacodynamic analysis) studies are proposed to investigate the effects of pregnancy on the aforementioned drug-metabolizing enzymes and transporters (second and third trimesters vs. 3 months postpartum period).
2. We aim to determine the efficacy and safety of insulin vs. glyburide vs. glyburide plus metformin for treatment of gestational diabetes mellitus. A Phase III efficacy and safety trial is proposed to evaluate the effects of gestational diabetes as well as the treatments on maternal, fetal and infant / child developmental outcomes.
描述(由申请人提供):该赠款提案的总体目标是在华盛顿大学建立一个产科药理学部门。药理学单元的主要目标是表征妊娠期间具有治疗价值的药物的药代动力学和药效学,并且其临床药理学因孕妇状态而改变。一般研究重点是细胞色素P450酶和膜转运蛋白。该建议描述了华盛顿大学的可用环境和资源,以建立成功且富有生产力的产科药理学研究部门。为了证明我们的研究兴趣和能力,提出了以下转化研究,这些研究将我们在临床和基本科学中的优势整合到评估以下研究的目的。
1。我们旨在确定使用以下表型标记物通过妊娠阶段改变了CYP2C9和有机阳离子转运蛋白(OCT)的体内活性:CYP2C9的Glyburide和OCT的二甲双胍。提出了I期(人群药代动力学分析)和II期(药代动力学 /药效分析)研究,以研究妊娠对上述药物 - 代谢酶和转运蛋白的影响(第二和第三个三个月和产后三个月)。
2。我们的目标是确定胰岛素与格列本卷与格列本伯里德的疗效和安全性以及二甲双胍治疗妊娠糖尿病。提出了一项III期疗效和安全试验,以评估妊娠糖尿病的影响以及对孕产妇,胎儿和婴儿 /儿童发育效果的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY F HEBERT其他文献
MARY F HEBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY F HEBERT', 18)}}的其他基金
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk
PBPK 建模
- 批准号:
10706040 - 财政年份:2023
- 资助金额:
$ 86.82万 - 项目类别:
Effects of Retinoids on CYP2D6 Activity and Variability in Special Populations
类维生素A对特殊人群中CYP2D6活性和变异性的影响
- 批准号:
9367390 - 财政年份:2017
- 资助金额:
$ 86.82万 - 项目类别:
Effects of Retinoids on CYP2D6 Activity and Variability in Special Populations
类维生素A对特殊人群中CYP2D6活性和变异性的影响
- 批准号:
9904729 - 财政年份:2017
- 资助金额:
$ 86.82万 - 项目类别:
EFFECTS OF PREGNANCY ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF GLYBURIDE
妊娠对格列本脲药代动力学和药效学的影响
- 批准号:
7603514 - 财政年份:2007
- 资助金额:
$ 86.82万 - 项目类别:
CYP3A5 AND CYCLOSPORINE/TACROLIMUS RENAL CLEARANCE
CYP3A5 和环孢素/他克莫司肾清除率
- 批准号:
7603506 - 财政年份:2007
- 资助金额:
$ 86.82万 - 项目类别:
UW Obstetric-Fetal Pharmacology Research Unit
华盛顿大学产胎儿药理学研究单位
- 批准号:
7354428 - 财政年份:2006
- 资助金额:
$ 86.82万 - 项目类别:
PHARMACOKINETICS OF AMOXICILLIN DURING PREGNANCY AND POSTPARTUM
阿莫西林在妊娠期和产后的药代动力学
- 批准号:
7379324 - 财政年份:2006
- 资助金额:
$ 86.82万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
- 批准号:
10825849 - 财政年份:2024
- 资助金额:
$ 86.82万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 86.82万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 86.82万 - 项目类别:
In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis
暴露于大麻的 HIV Tat 转基因小鼠食欲学习过程中的体内钙成像
- 批准号:
10696442 - 财政年份:2023
- 资助金额:
$ 86.82万 - 项目类别:
Is gestational sleep apnea a previously unrecognized cause of maternal immune activation that predisposes male offspring to disease-relevant neural dysfunction?
妊娠期睡眠呼吸暂停是否是一种以前未被认识到的母体免疫激活的原因,导致男性后代容易出现与疾病相关的神经功能障碍?
- 批准号:
10680972 - 财政年份:2023
- 资助金额:
$ 86.82万 - 项目类别: